CLEARREAD +CONFIRM

by RIVERAIN TECHNOLOGIES  · Based in United States → — Artificial Intelligence. Real Results.™
Critical Care Radiology

Not publicly available
Regulatory Status Disclosed

Overview

CLEARREAD +CONFIRM is part of Riverain Technologies’ ClearRead Xray suite, an AI-powered solution designed to enhance the interpretation of chest X-ray images. This specific application is engineered to generate an enhanced, secondary digital radiographic image of the chest, primarily to facilitate the confirmation and improved visibility of lines and tubes. By optimizing the visual quality of chest X-rays, including portable images, CLEARREAD +CONFIRM helps radiologists read up to 19% faster without compromising accuracy or confidence.

The ClearRead Xray suite, leveraging unique suppression technology and Clear Visual Intelligence™, provides an unimpaired view of the chest, revealing actionable data for the correct and rapid detection of cardiothoracic diseases. It is a workflow-friendly tool that integrates seamlessly into existing PACS/RIS environments, offering a cost-effective alternative to dual-energy subtraction without additional radiation dose or changes to existing imaging protocols for patients.

Riverain Technologies, founded in 2004, is a medical software innovator focused on revolutionizing early disease detection through artificial intelligence in cardiothoracic imaging. Their FDA-cleared ClearRead solutions are utilized by healthcare institutions globally to improve diagnostic accuracy, streamline radiologist workflow, and contribute to better patient outcomes, particularly in lung cancer screening and diagnosis.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Enhanced visibility of lines and tubes on chest X-rays
  • Reduces reading time for portable chest X-rays by approximately 19%
  • Maintains radiologist accuracy and confidence
  • Generates an enhanced, secondary digital radiographic image
  • Aids in critical care device confirmation
  • No additional radiation dose or changes to existing imaging protocols
  • Seamless integration into existing imaging workflows (PACS/RIS)
  • Optimizes portable chest X-rays for optimal and efficient visibility
  • Utilizes unique suppression technology for unimpaired chest view

Use Cases

  • Confirmation of lines and tubes in chest radiographs
  • Improving efficiency in reading portable chest X-rays
  • Enhancing diagnostic confidence for critical care device placement
  • General chest X-ray interpretation where lines/tubes are present
  • Streamlining radiologist workflow in high-volume environments

What Physicians Need to Know

DICOM Support & Standards
ClearRead +Confirm supports Digital Imaging and Communications in Medicine (DICOM) standards. It utilizes DICOM for capturing scans, routing capabilities, and filtering tools to selectively process or reject exams, devices, or patient demographics. The system relies on DICOM headers for patient position and orientation information. The output format for ClearRead XRay - Confirm is DICOM Secondary Capture.
PACS Integration Method
ClearRead +Confirm integrates seamlessly with Picture Archiving and Communication Systems (PACS). It allows radiologists to view ClearRead output as an additional series within their existing PACS review stations, eliminating the need for separate viewers, logins, or dedicated workstations. This integration is designed to maintain workflow consistency and can be deployed enterprise-wide.
Reading Room Workflow Impact
The software is designed to streamline reading time, improve accuracy, and ease the cognitive burden on radiologists. Studies have shown that ClearRead CT can reduce reading times by 26% to 36% and decrease missed actionable nodules by 29%. ClearRead XRay has been shown to improve nodule detection sensitivity by 17% and reduce reading times by 19%. The integration into existing PACS allows for a seamless workflow, avoiding the need for radiologists to switch applications.
AI Model Architecture (deep learning approach)
ClearRead solutions are built upon advanced AI algorithms, specifically deep learning, which is effective at recognizing patterns in complex images. This approach is used for tasks such as pulmonary nodule detection, coronary artery calcification (CAC) scoring, and pneumothorax detection. The AI models are trained on millions of images. Riverain's unique and patented suppression technology, powered by machine learning and advanced modeling, removes interfering structures like bones and vessels to provide an unimpaired view of the chest.
Processing Speed (per study)
ClearRead images process quickly, typically within minutes, and are available for review at the patient series. For ClearRead XRay - Confirm, the processing time is between 1 and 10 minutes.
FDA Clearance Pathway (510k/De Novo)
ClearRead +Confirm received 510(k) clearance from the FDA on December 27, 2012. Other ClearRead products, such as ClearRead CT and ClearRead Xray Pneumothorax, have also received 510(k) clearance.
Supported Modalities (CT/MRI/X-ray/US)
ClearRead +Confirm is designed for chest X-rays. The broader ClearRead suite offers solutions for both chest CT and X-ray. This includes ClearRead CT for pulmonary nodule detection, coronary artery calcification scoring, and hypodense lung tissue quantification, and ClearRead Xray for nodule and pneumothorax detection, and bone suppression.
Sensitivity & Specificity Data
ClearRead CT has been shown to improve nodule detection rates, with one study indicating a 21% greater nodule detection rate with vessel-suppressed CTs. Another study showed a 29% reduction in missed actionable nodules. For small pulmonary nodules (≤2 mm), detection rates increased from 13% to 24.2%. ClearRead Xray Bone Suppressed improved the detection of missed nodules by 17%. ClearRead CT CAC demonstrated high agreement with ground truth radiologists (0.959) and paired cardiac gated CT (0.906) for Agatston scoring.
RSNA/ACR Validation
Studies on Riverain's ClearRead technology, including those on vessel suppression and coronary artery calcification scoring, have been presented at RSNA annual meetings. Riverain Technologies also participates in RSNA events to showcase enhancements to its ClearRead AI platform.
Physician Tip

ClearRead +Confirm is designed to enhance chest X-ray clarity and aid in the proper placement of tubes, lines, and wires by selectively increasing contrast and suppressing clavicles and ribs. For CT scans, the vessel suppression feature can significantly improve the visibility of pulmonary nodules, including solid, part-solid, and ground glass types, and is cleared for concurrent reading. The automated nodule analysis, including volume and diameter measurements, and the ability to compare current and prior exams, can aid in efficient monitoring of nodule changes. The incidental coronary artery calcification (CAC) scoring on ungated, non-contrast CTs can be a valuable tool for cardiovascular risk assessment. The system's ability to integrate seamlessly into existing PACS and provide results within minutes can help maintain workflow efficiency.

ClearRead +Confirm integrates directly into existing PACS as an additional series in the patient study, eliminating the need for separate applications or logins. It supports DICOM standards for image input and output. The ClearRead Chest suite is also available through AI platforms and marketplaces, such as RapidAI's Enterprise Platform and Aidoc's aiOS platform, offering broader access and integration with other clinical AI tools and hospital systems like EHRs and reporting systems. Deployment options include stand-alone servers, virtual machines, or cloud environments.

Details

Category Radiology & Imaging AI
Pricing Not publicly available
DeploymentOn-premise (server, virtual machine) or cloud
Compliance
BAA AvailableUnknown
HIPAA CompliantUnknown
FDA Status Cleared AI-estimated
Integrations
EHR Not specified
Specialties Critical Care, Radiology

What the Web Says

ClearRead +Confirm is an AI-powered software designed to assist radiologists in detecting and confirming lung nodules on chest X-rays. It aims to improve diagnostic accuracy and efficiency by highlighting suspicious areas, potentially reducing missed findings and streamlining workflows.

Overall: Positive

Strengths

  • Aids in earlier detection of lung nodules
  • Reduces variability in interpretation among radiologists
  • Integrates with existing PACS systems
  • Can improve radiologist confidence in diagnoses
  • Potential to decrease false negatives
  • Designed to enhance workflow efficiency

Limitations

  • Relies on the quality of the input X-ray images
  • May require a learning curve for new users
  • Potential for over-reliance on AI by radiologists
  • Cost of implementation and maintenance
  • Requires ongoing validation and updates
  • Limited to lung nodule detection on chest X-rays

Based on reviews from: Riverain Technologies website, various medical imaging journals and articles (general understanding of AI in radiology), healthcare technology reviews (general understanding of AI in healthcare)

Last updated: 2026-10-31

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate CLEARREAD +CONFIRM

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

Riverain Technologies
What role is AI playing in Northeast Ohio hospitals? Experts weigh in.
This article discusses the role of AI in Northeast Ohio hospitals, featuring insights from experts, likely including Riverain Technologies' contributions to healthcare AI.
2026-03
JobsOhio
Riverain Technologies Expanding to Drive Growth and Advance Health Tech Innovation
Riverain Technologies announced its expansion, creating 48 new jobs in Miamisburg, Ohio, to further its mission of transforming radiology through AI tools like ClearReadu2122 for improved diagnostic accuracy and patient outcomes.
2026-01
Riverain Technologies
VIDA Partners with Riverain Technologies to Extend Best-of-Breed AI Imaging for Life Sciences
VIDA and Riverain Technologies have partnered to integrate their AI imaging solutions, aiming to enhance life sciences research and applications.
2025-11
Riverain Technologies
deepc Enriches Enterprise Health AI Portfolio with Riverain Technologies' ClearReadu2122 solutions on deepcOSu00ae
deepc has integrated Riverain Technologies' ClearReadu2122 solutions into its deepcOSu00ae platform, expanding its enterprise health AI portfolio to improve diagnostic capabilities.
2025-11
Riverain Technologies
Study Shows ClearReadu2122 CT CAC for Incidental Coronary Artery Calcification Highly Effective on Ungated CT Exams
A study demonstrated the high effectiveness of ClearReadu2122 CT CAC in detecting incidental coronary artery calcification on ungated CT exams, highlighting its potential for opportunistic screening of heart disease.
2025-11
Riverain Technologies
Bialogics and Riverain Set the New Benchmark for AI Adoption
Bialogics and Riverain Technologies have collaborated to establish new standards for AI adoption in healthcare, focusing on integrating AI into clinical workflows.
2025-11
DAIC
Riverain Technologies Launches New FDA-Cleared Technology, Expands Globally
Riverain Technologies announced its global expansion across eight countries and the launch of new FDA-cleared technology that extends ClearRead CT functionality to provide coronary artery calcium scores for ungated scans.
2025-02

Videos

Product demos, reviews, and walkthroughs for CLEARREAD +CONFIRM.

View all on YouTube

Frequently Asked Questions

CLEARREAD +CONFIRM is an AI-powered software designed to enhance portable chest X-ray images by identifying and highlighting lines and tubes. This technology helps radiologists minimize imaging adjustments and can reduce reading time by approximately 19% without compromising accuracy or confidence.
CLEARREAD +CONFIRM has received FDA 510(k) clearance in the United States and CE Mark in Europe. It is intended for use by trained professionals, such as physicians and radiologists, on adult patients with lines and tubes, and is not a substitute for the original PA/AP image or full patient evaluation.
CLEARREAD +CONFIRM is specifically intended for enhancing chest X-rays to improve the visibility of lines and tubes and is not intended for use on pediatric patients. It provides adjunctive information and should not be used in lieu of full patient evaluation or relied upon to make or confirm diagnoses.
Yes, there are several alternatives in the market for AI-powered radiology solutions. For lung nodule detection on CT, alternatives to Riverain's ClearRead CT include Coreline AVIEW Lung Nodule CAD, Infervision InferRead Lung CT.AI, Fujifilm Synapse Lung Nodule AI, and Siemens syngo.CT Lung CAD. Other companies like Aidoc, Qure.ai, and Infervision also offer various AI solutions for chest imaging and other radiological tasks.
CLEARREAD +CONFIRM is designed for universal integration with patient data management programs and can be deployed enterprise-wide on any acquisition device and PACS. It integrates into standard reading environments (PACS) and can also be integrated via AI marketplaces or distribution platforms, sending enhanced images back into PACS for side-by-side review.

Related Tools

a2z Radiology AI Inc.
a2z Radiology AI Inc.
Clinical Decision Support & Reference
Abdo-Triage is an AI tool by a2z Radiology AI Inc. designed to assist radiologists in triaging abdominal imaging studies and identifying critical findings.
Perimeter Medical Imaging AI
Perimeter Medical Imaging AI
Clinical Decision Support & Reference
The Claire OCT System by Perimeter Medical Imaging AI uses Optical Coherence Tomography and AI to provide real-time, high-resolution tissue imaging during surgery to help identify cancerous tissue.
SOPHiA DDM
SOPHiA GENETICS
Oncology AI
SOPHiA DDM™ is an AI-driven and cloud-powered platform that helps clinicians generate real-time, actionable insights for patients with cancer and rare disorders by analyzing complex genomic, radiomic, and multimodal data.
Qure.ai QXR
Qure.ai
Clinical Decision Support & Reference
Qure.ai QXR is an AI-powered solution for chest X-ray interpretation, designed to assist radiologists, pulmonologists, and ER physicians in diagnosing various conditions.
DeepBio DeepDx® Prostate
DeepBio
Oncology AI
DeepDx® Prostate leverages deep learning to standardize prostate cancer diagnostics by detecting abnormalities in digital slides with high precision, providing automated Gleason grading, tumor quantification, and tumor length measurements.
CortiCare (Virtual EEG Department)
CortiCare
Neurology AI
CortiCare offers 24/7 remote EEG monitoring and interpretation services, functioning as a virtual EEG department to assist hospitals and neurology practices in identifying seizures and other neurological conditions.

See all Radiology & Imaging AI tools →

More from Riverain Technologies

ClearRead CT
RIVERAIN TECHNOLOGIES
Cardiology AI
ClearRead CT is an FDA-cleared AI suite by Riverain Technologies for cardiothoracic health, enhancing pulmonary nodule detection and coronary artery calcification analysis in CT scans. It improves diagnostic accuracy, reduces reading times, and streamlines radiology workflows through advanced AI and vessel suppression technology.
ClearRead CT CAC
Riverain Technologies
Cardiology AI
ClearRead CT CAC by Riverain Technologies is an AI-powered software that enables opportunistic screening for coronary artery calcification (CAC) by accurately detecting, quantifying, and reporting Agatston scores from routine, ungated, non-contrast chest CT scans.
ClearRead Xray Pneumothorax
Riverain Technologies
Radiology & Imaging AI
ClearRead Xray Pneumothorax is an AI-driven tool by Riverain Technologies that provides triage notification for suspected pneumothorax (5mm or larger) on adult chest X-rays, aiming for early detection and improved radiologist efficiency.
DELTAVIEW MODEL
Riverain Technologies
Oncology AI
DELTAVIEW MODEL, by Riverain Technologies (formerly Riverain Medical Group), is an AI-driven medical imaging software for temporal comparison of chest X-rays, designed to detect subtle changes like early-stage lung cancer nodules through bone suppression and image subtraction technology.

View company profile →

Suggest an Edit → | Report an issue | Last Verified: 2026-04-19 | First Added: 2026-04-19
AI Tool Finder
AI-powered search. Results may not be comprehensive.